|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| (11) | Number of the document | 3219727 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16160918.5 |
| Date of filing the European patent application | 2016-03-17 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation | 2021-02-10 |
| (72) |
GUNDE, Tea, CH
MEYER, Sebastian, CH
FURRER, Esther Maria, CH
|
| (73) |
Tillotts Pharma AG,
Baslerstrasse 15, 4310 Rheinfelden,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-TNF alfa antikūnai ir jų funkciniai fragmentai |
| ANTI-TNF ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-03-05 | 11 | 289.00 EUR |
| 2027-03-17 |